Pepsi's slump is mainly due to aggressive price hikes and high T-bond yields, not diworsification or health trends.

GLP-1 receptor agonists (GLP-1 RAs), medications that help control type 2 diabetes and obesity, can have a profound impact on ...

Much has been learned about GLP-1s over many years, but little is understood about why the degree of response to them varies ...